Tubuloreticular structures in human lymphoid cell lines. A cell biological study.
Human lymphoid cell lines were studied as an experimental model for the spontaneous or induced occurrence of tuburloreticular structures (TRS). It was possible to induce TRS after culturing the EB-3 cell line with 20 mug/ml bromodeoxyuridine (BrUdR) during 96 h. Starvation, culturing at lower temperature (32 degrees) or inhibition of DNA synthesis did not give rise to the production of TRS. The response to BrUdR could be blocked with 60 mug/ml thymidine but not with 60 mug/ml deoxycytidine. The addition of 5 mug/ml cytarabine or the removal of BrUdR at different times resulted in inhibition of TRS induction, indicating that BrUdR had to be incorporated into DNA during at least 48 h. After incorporation, neither the presence of BrUdR nor DNA synthesis was necessary for the production of TRS. These experiments and the finding that in the cell line IHTC-33, which does not produce Epstein-Barr virus associated antigens, TRS were spontaneously present, exclude a correlation between TRS and these antigens. However, the induction of TRS by BrUdR may be related to the activation of another (latent) virus.
D000956:Antigens, Viral / Q000032:analysis; D001973:Bromodeoxyuridine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002460:Cell Line; D002478:Cells, Cultured; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003841:Deoxycytidine / Q000494:pharmacology; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D002479:Inclusion Bodies / Q000648:ultrastructure*; D008214:Lymphocytes / Q000648:ultrastructure*; D013696:Temperature; D013936:Thymidine / Q000494:pharmacology
D000956:Antigens, Viral; D003561:Cytarabine; D003841:Deoxycytidine; D004247:DNA; D001973:Bromodeoxyuridine; D013936:Thymidine